Tema Cardiovascular and Metabolic ETF (HRTS) Performance
HRTS total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +6.1% since Dec 31, 2025
- 1 year
- +17.6% total return
- Since first price
- +44.7% since 2023
HRTS trailing returns vs SPY, QQQ, AGG
| Period | HRTS total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | +3.9% | +3.9% | −1.0% | −5.0% | +0.9% |
| 3 months | +2.9% | +2.9% | +3.2% | +1.9% | −0.4% |
| 6 months | +11.0% | +11.0% | +7.8% | +8.4% | −1.5% |
| YTD | +6.1% | +6.1% | +12.3% | +15.1% | −1.0% |
| 1 year | +17.6% | +16.0% | +14.4% | +15.9% | −1.1% |
| Since inceptionNov 21, 2023 | +44.7% | +40.7% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: HRTS vs SPY
From Nov 21, 2023: HRTS grew to $14,472, SPY to $17,385.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
HRTS returns by calendar year
1 of 2 full years positive. Best 2025 (+23.9%), worst 2024 (−4.3%). 2026 is year to date.
HRTS annual returns table
| Year | HRTS | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +6.1% | −11.0% | +12.3% | +15.1% | −1.0% |
| 2025 | +23.9% | −15.1% | +17.7% | +20.8% | +7.2% |
| 2024 | −4.3% | −18.4% | +24.9% | +25.6% | +1.3% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
HRTS largest drawdowns
Now 3.6% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Jul 16, 2024 | −25.8% | Apr 8, 2025 | Nov 25, 2025 | 9 months | 1.4 years |
| Mar 1, 2024 | −11.7% | Apr 19, 2024 | Jul 11, 2024 | 49 days | 4 months |
| Jan 7, 2026 | −11.0% | Mar 27, 2026 | Jun 29, 2026 | 3 months | 6 months |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
HRTS risk statistics
| Statistic | Since 2023 |
|---|---|
| Annualized return | +12.5% |
| Volatility (annualized) | 17.7% |
| Sharpe ratio | 0.51 |
| Sortino ratio | 0.81 |
| Best month | +14.3% |
| Worst month | −9.9% |
| Best 12 months | +32.6% |
| Worst 12 months | −17.5% |
| Positive months | 62% |
| Beta vs S&P 500 | — |
| Correlation with S&P 500 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
HRTS rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 24 | −17.5% | +14.2% | +32.6% | 58% |
Every holding period starting at a month-end since 2023. Returns for 3 years and longer are annualized.
HRTS performance overview
Tema Cardiovascular and Metabolic ETF (HRTS) returned +17.6% over the past year, with distributions reinvested. Since its first recorded price on Nov 21, 2023 it has returned +44.7%. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −25.8%, from Jul 16, 2024 to Apr 8, 2025, and it took 8 months to get back to the old high. Volatility has been 17.7% a year.
Related: HRTS chart, HRTS holdings, HRTS dividends, HRTS valuation. See the HRTS overview for the latest quote and fund facts.
HRTS performance FAQ
What is the HRTS return over the past year?
HRTS returned +17.6% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 16.0%.
How much would $10,000 invested in HRTS be worth?
$10,000 invested in HRTS at its first recorded close on November 21, 2023 would be worth about $14,472 on October 23, 2026 with distributions reinvested.
What was the worst year for HRTS?
The worst calendar year was 2024, with a total return of −4.3%. The best was 2025 at +23.9%.
What is the biggest drawdown of HRTS?
The largest peak-to-trough decline was −25.8% between July 16, 2024 and April 8, 2025. It recovered to the old high on November 25, 2025, 8 months after the bottom.
How volatile is HRTS?
Over the past history HRTS had an annualized volatility of 17.7% and a Sharpe ratio of 0.51 (excess return over 1–3 month T-bills per unit of risk).